Post-earnings recap
Reported
Thu, May 10, 2018
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
75%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Aurinia Pharmaceuticals reported an EPS of $0.18, but there was no revenue figure provided. The stock reacted positively, increasing by 0.77%. The lack of guidance and commentary from management leaves investors with limited insight into future performance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.18 | N/A | — |
| Revenue | — | N/A | — |
No transcript is on record for this earnings call, so the analysis is based solely on numerical results.